July 3, 2019
- Teplizumab delays onset of type 1 diabetes mellitus (HTML)
- A better way to encapsulate islet cells for diabetes treatment
- Effect of hyperglycemia on cerebral blood flow in patients with diabetes
- Seeking Surrogate Markers for Diabetic Macular Edema
- Association Between Change in Visual Acuity and Change in Central Subfield Thickness During Treatment of Diabetic Macular Edema in Participants Randomized to Aflibercept, Bevacizumab, or Ranibizumab
- Microbiome and type 1 diabetes (HTML)
- Oral insulin therapy for primary prevention of type 1 diabetes in infants with high genetic risk: the GPPAD-POInT (global platform for the prevention of autoimmune diabetes primary oral insulin trial) study protocol (HTML)
- Serum uromodulin is associated with urinary albumin excretion in adolescents with type 1 diabetes (HTML)
- Diagnosis of cyclic Cushing’s disease manifests as early morning hyperglycemia in a patient with previously well-controlled type 1 diabetes (HTML)
- Novel Single-Site Device for Conjoined Glucose Sensing and Insulin Infusion: Performance Evaluation in Diabetes Patients During Home-Use (HTML)
- Metabolic health and vascular complications in type 1 diabetes (HTML)
- Characterization of host defense molecules in the human pancreas (HTML)
- Persistent C-peptide levels and microvascular complications in childhood onset type 1 diabetes of long duration (HTML)